Recent Updates
Recently added Catalysts
SBC Positive Sentiment

SBC Medical to Announce 3Q 2026 Financial Results

Key Takeaway: SBC Medical Group Holdings will release its Q3 2026 financial results on November 13, 2026, before market open. An earnings conference call will follow at 8:30 a.m. ET, allowing for a Q&A session with investors. The company continues to expand its services and enhance its reputation in the healthcare sector.

Market Sentiment Analysis

POSITIVE FACTORS

  • SBC Medical is expanding its global presence.
  • The company is actively involved in various healthcare fields.
  • SBC Medical was included in the Russell 3000 Index.

Full Press Release Details

IRVINE, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“The Company” or “SBC Medical”), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields, today announced that it will release its financial results for the third quarter ended September 30, 2026, before U.S. market open on November 13, 2026.
Management will host an earnings conference call on November 13, 2026, at 8:30 a.m. Eastern Time. A question-and-answer session with investors and analysts will follow the prepared remarks.
Please register in advance for the conference using the link provided below.
Additionally, the earnings release, accompanying slides, and an archived webcast of this conference call will be available at the Company’s Investor Relations website at https://ir.sbc-holdings.com/
About SBC Medical Group Holdings Incorporated SBC Medical is a Medical Services Organization providing management support across a wide range of healthcare fields, including advanced aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, hair loss treatment (AGA), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose “Contributing to the well-being of people around the world through medical innovation,” SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.
For more information, visit https://sbc-holdings.com For more insights and updates from SBC Medical, follow us on LinkedIn.
Forward-Looking Statements This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company’s beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company’s control. These forward-looking statements reflect the Company’s current views with respect to, among other things, the Company’s plans and strategies for service expansion; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” “targets” or “hopes” or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management’s current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading “Risk Factors” and elsewhere in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”), which are accessible on the SEC’s website at www.sec.gov.

Contacts Hikaru Fukui / Head of IR Department; E-mail: ir@sbc-holdings.com

Frequently Asked Questions

When will SBC Medical announce its Q3 2026 results?

SBC Medical will announce its Q3 2026 results on November 13, 2026.

What time is the earnings conference call?

The earnings conference call is scheduled for 8:30 a.m. ET on November 13, 2026.

Where can I find SBC Medical's financial results?

The financial results will be available on SBC Medical's Investor Relations website.

What is the significance of the Russell 3000 Index for SBC?

SBC Medical was included in the Russell 3000 Index, enhancing its market visibility.

Last updated: Nov 3, 2026